3 superior target actions to consider buying before they recover

He Alternative investment market (AIM) It does not have the best reputation. In addition to containing many non -profitable companies that are more likely to bend than expand, AIM stocks can be very volatile. However, I think there are at least a few raw diamonds to consider buying.

TANKING ACCOUNT PRICE

Bioventix (LSE: BVXP) is possibly an example. Actions in the developer and commercial supplier of monoclonal antibodies have fallen more than 40% in the last 12 months. While some of this is likely to be the result of broader concerns in the market, much is due to the company that exaggerates income in £ 327,000 as a result of a customer error. Actually, the company's real income occurred below market expectations.

This news has clearly shaken trust and has led the actions to a minimum of several years.

However, I think this could be a good time to think about the load. As worrying as the recent form has been, it remains a company that stinks from quality. The margins and returns of capital are still high, thanks in part to having very few employees. While this has led to the negotiation of shares with a broader premium, the current relationship ratio (P/E) of 16 is already significantly lower than the average of 27 years of the company.

It is worth reading half -year numbers, defeated on March 24. I think only a small crack of light will be needed so that the actions move in the right direction again.

Sales

Another niche company that quotes on the objective that you consider to have been mistreated is the manufacturer of laser -guided equipment Summer companies (LSE: Som). The price of its action has already fallen almost 20% in 2025.

So what has gone wrong here? Well, investors have been increasingly concerned about the general economic perspectives, particularly in the United States (where it is based on the company) that constitutes three quarters of sales. There is the possibility that things go from bad to worse if interest rates remain higher for longer and force customers to delay the purchase of the company's cement level technology.

However, like Bioventix, this is another small capitalization that obtains consistently well in quality metrics. With the support of a solid balance and a very experienced management, Boom is also a market leader in what he does. Although it is never guaranteed, dividend yield currently also has 6.8% fleshy.

Monster dividend yield

A final tip stock that is worth reflecting is the base metal producer Central Asia Metals (LSE: CAML). As the other two mentioned here, their actions have fallen in recent times, 14% or so in the last 12 months.

Again, much of this seems to be the result of general geopolitical concerns. That said, the lead demand has been lower. The company drills this (and zinc) in its mine in northern Macedonia. It also has copper operations in Kazakhstan.

In a more positive note, the shares now produce an incredible 10% for fiscal year 2015. If investors will see all this cash is open to debate if the costs continue to increase. However, the total dividend is expected to be covered by profits as things are. The action is also very cheap, changing from hands to a p/e of only seven for fiscal year 2015.

Full year numbers are due tomorrow (March 20). It will be interesting to see how current holders react.